Form 4: BioMarin CFO Brian Mueller Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Brian Mueller, EVP and CFO of BioMarin Pharmaceutical Inc., disposed of 588 shares of common stock on June 28, 2024, to cover tax obligations.
Summary
- On June 28, 2024, Brian Mueller, the EVP and Chief Financial Officer of BioMarin Pharmaceutical Inc., disposed of 588 shares of the company's common stock.
- The transaction was executed at a price of $82.33 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Mueller directly owns 71,571 shares of BioMarin common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact sentiment. It's a neutral event.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of stock disposal transaction |
| 07/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.